Deborah T. Cirkel

616 total citations
8 papers, 529 citations indexed

About

Deborah T. Cirkel is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Deborah T. Cirkel has authored 8 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Deborah T. Cirkel's work include Diabetes Treatment and Management (6 papers), Diabetes Management and Research (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Deborah T. Cirkel is often cited by papers focused on Diabetes Treatment and Management (6 papers), Diabetes Management and Research (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Deborah T. Cirkel collaborates with scholars based in United Kingdom, United States and France. Deborah T. Cirkel's co-authors include Murray Stewart, Caroline Perry, Bo Åhrén, Mark N. Feinglos, Fred Yang, Susan Johnson, Peter N. Weissman, Molly C. Carr, Jane E.B. Reusch and June Ye and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Deborah T. Cirkel

8 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah T. Cirkel United Kingdom	8	463	221	157	110	49	8	529
Silvia Ciani Italy	5	295 0.6×	197 0.9×	138 0.9×	60 0.5×	88 1.8×	5	411
Chang Yu Pan China	9	315 0.7×	123 0.6×	94 0.6×	47 0.4×	55 1.1×	12	375
Burkhard Goeke Germany	6	405 0.9×	146 0.7×	201 1.3×	104 0.9×	32 0.7×	13	513
Yuichi Terawaki Japan	10	299 0.6×	235 1.1×	130 0.8×	36 0.3×	83 1.7×	13	422
Wenying Huang United States	5	222 0.5×	171 0.8×	78 0.5×	57 0.5×	42 0.9×	9	362
Masako Tomoyasu Japan	8	462 1.0×	187 0.8×	219 1.4×	80 0.7×	57 1.2×	10	574
Yunshan Hu Australia	7	301 0.7×	160 0.7×	116 0.7×	70 0.6×	23 0.5×	7	396
Kasper Aaboe Denmark	8	486 1.0×	182 0.8×	274 1.7×	62 0.6×	61 1.2×	12	565
Diane L. Möller-Goede Netherlands	5	313 0.7×	101 0.5×	140 0.9×	31 0.3×	50 1.0×	7	340
Markus Niggli Switzerland	13	190 0.4×	162 0.7×	103 0.7×	64 0.6×	98 2.0×	25	1.2k

Countries citing papers authored by Deborah T. Cirkel

Since Specialization

Citations

This map shows the geographic impact of Deborah T. Cirkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah T. Cirkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah T. Cirkel more than expected).

Fields of papers citing papers by Deborah T. Cirkel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah T. Cirkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah T. Cirkel. The network helps show where Deborah T. Cirkel may publish in the future.

Co-authorship network of co-authors of Deborah T. Cirkel

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah T. Cirkel. A scholar is included among the top collaborators of Deborah T. Cirkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah T. Cirkel. Deborah T. Cirkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Pozzilli, Paolo, Emanuele Bosi, Deborah T. Cirkel, et al.. (2020). Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 105(6). e2192–e2206. 24 indexed citations

Home, Philip, Bo Åhrén, Jane E.B. Reusch, et al.. (2017). Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy. Diabetes Research and Clinical Practice. 131. 49–60. 33 indexed citations

Reusch, Jane E.B., Murray Stewart, Christopher Perkins, et al.. (2014). Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonist albiglutide ( HARMONY 1 trial): 52‐week primary endpoint results from a randomized, double‐blind, placebo‐controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin. Diabetes Obesity and Metabolism. 16(12). 1257–1264. 98 indexed citations

Weissman, Peter N., Molly C. Carr, June Ye, et al.. (2014). HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea. Diabetologia. 57(12). 2475–2484. 115 indexed citations

Åhrén, Bo, Susan Johnson, Murray Stewart, et al.. (2014). HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin. Diabetes Care. 37(8). 2141–2148. 195 indexed citations

Stewart, Murray, Deborah T. Cirkel, Kristian Furuseth, et al.. (2006). Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well‐controlled Type 2 diabetes. Diabetic Medicine. 23(10). 1069–1078. 29 indexed citations

Skovsgaard, Torben, N. Davidson, Martine Piccart, et al.. (2001). A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer. Annals of Oncology. 12(9). 1255–1257. 11 indexed citations

Smith, Ian E., Stephen R.D. Johnston, Mary O’Brien, et al.. (2000). Low-Dose Oral Fluorouracil With Eniluracil as First-Line Chemotherapy Against Advanced Breast Cancer: A Phase II Study. Journal of Clinical Oncology. 18(12). 2378–2384. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact